Post-approval studies (Phase 4)Study completedNCT03158038
What this trial is testing
Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season
Who this might be right for
InfluenzaHealthy
MedImmune LLC 300